Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Protagonist Therapeutics, Inc (PTGX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/03/2023 8-K Quarterly results
Docs: "Protagonist Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
07/05/2023 8-K Quarterly results
07/03/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
06/02/2023 4 Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 12,000 shares @ $0
Paid exercise price by delivering 4,150 shares @ $26.07, valued at $108.2k
06/02/2023 4 PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Gifted 10,000 shares @ $0
Granted 30,000 shares @ $0
Paid exercise price by delivering 12,165 shares @ $26.07, valued at $317.1k
06/02/2023 4 Ali Asif (CFO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 12,000 shares @ $0
Paid exercise price by delivering 4,150 shares @ $26.07, valued at $108.2k
05/30/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
Docs: "Protagonist Reports First Quarter 2023 Financial Results and Provides Corporate Update"
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
04/04/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/20/2023 SC 13G BIOTECHNOLOGY VALUE FUND L P reports a 9.6% stake in Protagonist Therapeutics, Inc.
03/15/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/15/2023 10-K Annual Report for the period ended December 31, 2022
03/15/2023 8-K Quarterly results
Docs: "Protagonist Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update"
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A Farallon Capital Partners, L.P. reports a 10% stake in Protagonist Therapeutics, Inc.
01/31/2023 SC 13G/A BlackRock Inc. reports a 7.4% stake in Protagonist Therapeutics, Inc
01/18/2023 4 Giraudo Bryan (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 30,000 options to buy @ $12.17, valued at $365.1k
01/18/2023 4 Williams Lewis T (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 30,000 options to buy @ $12.17, valued at $365.1k
01/18/2023 4 Waddill William D. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 30,000 options to buy @ $12.17, valued at $365.1k
01/18/2023 4 Noonberg Sarah B. (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 30,000 options to buy @ $12.17, valued at $365.1k
01/18/2023 4 O'Dowd Sarah A (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 30,000 options to buy @ $12.17, valued at $365.1k
01/18/2023 4 SELICK HAROLD E (Director) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 30,000 options to buy @ $12.17, valued at $365.1k
01/18/2023 4 Gupta Suneel (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 20,625 shares @ $0
Granted 123,750 options to buy @ $12.17, valued at $1.5M
01/18/2023 4 Ali Asif (CFO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 10,625 shares @ $0
Granted 63,750 options to buy @ $12.17, valued at $775.8k
01/18/2023 4 MOLINA ARTURO MD (Chief Medical Officer) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Granted 3,125 shares @ $0
Granted 18,750 options to buy @ $12.17, valued at $228.2k
01/18/2023 4 PATEL DINESH V PH D (President and CEO) has filed a Form 4 on Protagonist Therapeutics, Inc
Txns: Gifted 3,000 shares @ $0
Gifted 3,116 shares @ $0
Granted 600,000 options to buy @ $12.17, valued at $7.3M
01/11/2023 SC 13G/A JOHNSON & JOHNSON reports a 5% stake in Protagonist Therapeutics, Inc.
01/10/2023 SC 13G/A STATE STREET CORP reports a 7.7% stake in AMENDED FILING PROTAGONIST THERAPEUTICS INC
01/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy